White paper: Streamlining Pharma Operations in the Wake of COVID-19


COVID-19 is shedding further light on pharmaceutical sourcing strategies and their inherent complexity, explains Jim Morris

NSF's white paper from Jim Morris discusses the importance of streamlining pharma operations in a COVID-19 environment.

He highlights the vital areas that will warrant leadership attention including supplier oversight, inspection readiness and the impact on personnel.

Sign up for your free email newsletter

Click here to download the white paper.

Featured Companies